Air Force tactical air control party (TACP) operators from the 19th Air Support Operations Squadron underwent a comprehensive ...

NASA is pushing ahead with an Artemis 2 launch as soon as April 1 after completing repairs to a helium line that required ...

The dipeptidyl peptidase-1 (DPP1) inhibitor brensocatib became the first licensed therapy for bronchiectasis in the USA and Europe in 2025,1 based on the phase 3 ASPEN trial showing an approximate 20% ...

A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...

President Donald Trump’s administration formally launched the second phase of its plan to end the war between Israel and Hamas this week, shifting from a ceasefire framework toward a post-ceasefire ...

The current era of Stranger Things is officially over, bookended by a new documentary that aired yesterday on Netflix and was picked apart by jilted fans, but was, in reality, pretty standard ...

Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...

Kelluu produces hydrogen-powered airships, providing aerial sensing capability as a service. Above, testing during NATO ‘REPMUS 2025'. (NATO DIANA) NATO's Defence Innovation Accelerator for the North ...

On this date six years ago, the graffiti world and the entire Hip Hop community lost one of its most influential pioneers. Michael Lawrence Marrow, better known as True Mathematics Allah and globally ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that the first participant has been enrolled in the BLOOM Phase 2 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...